Answers are grounded in this paper and cite their sources.
Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.
No takes yet. Share an insight, caveat, or question.
Akbarialiabad et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: